FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

Fast Track Designation Highlights the Urgent Need for New Heart Failure Treatment Options THOUSAND OAKS, CA…

Amgen Completes Acquisition Of Otezla® (apremilast)

(STL.News) – Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to…

Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia

(STL.News) –  Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen’s…

Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen’s Myeloma MVP™ Team

(STL.News) – Amgen (NASDAQ:AMGN) today announced the expansion of Myeloma MVP™, a national initiative to help…

US District Court Invalidates Amgen Patent Claims Targeting PCSK9

Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation (STL.News) –…

Bristol-Myers Squibb Announces Agreement Between Celgene, Amgen to Divest OTEZLA® for $13.4 Billion

Agreement Contingent on FTC Consent Decree and Closing of Pending Bristol-Myers Squibb-Celgene Merger Pending Bristol-Myers Squibb-Celgene…

Business News: Amgen Announces 2019 Third Quarter Dividend

THOUSAND OAKS, CA (STL.News) – Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a…